Screening for LTBI prior to anti-TNFα initiation was negative in 20 (67%) of 30 patients; among the other 10 patients, 6 (21%) were treated for LTBI, 1 (3%) for pulmonary TB, and 3 (8%) had no screening. The gene discussed is TNF; the disease is pulmonary tuberculosis.